{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:41:41Z","timestamp":1789994501355,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"French Government"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ijantimicag.2018.01.027","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T12:42:56Z","timestamp":1517834576000},"page":"775-783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates"],"prefix":"10.1016","volume":"51","author":[{"given":"Liliane","family":"Okdah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Le Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiola Olumuyiwa","family":"Olaitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Dubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Rolain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2049936115621709","article-title":"Carbapenem resistance: overview of the problem and future perspectives","volume":"3","author":"Meletis","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1586\/eri.12.78","article-title":"Colistin: an update on the antibiotic of the 21st century","volume":"10","author":"Biswas","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3389\/fmicb.2014.00643","article-title":"Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria","volume":"5","author":"Olaitan","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0025","first-page":"21","article-title":"Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium","volume":"2016","author":"Xavier","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0030","article-title":"Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli","volume":"8","author":"Yin","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism mcr-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00317-17","article-title":"Emergence of the plasmid-mediated mcr-1 gene in clinical KPC-2-producing Klebsiella pneumoniae sequence type 392 in Brazil","volume":"61","author":"Aires","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0045","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ijantimicag.2017.06.011","article-title":"Colistin-resistance gene mcr-1 in gut flora of children","volume":"50","author":"Hu","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0050","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1128\/AAC.01486-16","article-title":"Acquisition of mcr-1 plasmid-mediated colistin resistance in Escherichia coli and Klebsiella pneumoniae during Hajj 2013 and 2014","volume":"60","author":"Leangapichart","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jgar.2017.05.004","article-title":"mcr-1 plasmid-mediated colistin resistance gene detection in an Enterobacter cloacae clinical isolate in France","volume":"10","author":"Baron","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0060","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijantimicag.2016.09.014","article-title":"Synergistic combinations of polymyxins","volume":"48","author":"Lenhard","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/infdis\/121.5.555","article-title":"The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens","volume":"121","author":"Greenfield","year":"1970","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0070","first-page":"211","article-title":"Ultrastructural changes produced in Proteus vulgaris by a synergistic combination of colistin and sulphadiazine","volume":"10","author":"Handley","year":"1974","journal-title":"Microbios"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0075","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1128\/AAC.05996-11","article-title":"In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates","volume":"56","author":"Vidaillac","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0080","series-title":"M100-S22: Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0085","series-title":"European Committee on Antimicrobial Susceptibility Testing","year":"2017"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijantimicag.2011.10.001","article-title":"Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii","volume":"39","author":"Kempf","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0095","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","article-title":"Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test","volume":"40","author":"White","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijantimicag.2016.06.023","article-title":"Molecular mechanisms of polymyxin resistance: knowns and unknowns","volume":"48","author":"Baron","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/dkw377","article-title":"Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis","volume":"72","author":"Zusman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/jcp.16.4.362","article-title":"Synergism between sulphonamide drugs and antibiotics of the polymyxin group against Proteus sp. in vitro","volume":"16","author":"Russel","year":"1963","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jcp.23.9.757","article-title":"Colistin, sulphamethoxaole, and trimethoprim in synergy against Gram-negative bacteria","volume":"23","author":"Simmons","year":"1970","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0120","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/AAC.3.4.523","article-title":"Synergism of polymyxin and sulfonamides in L-forms of Staphylococcus aureus and Proteus mirabilis","volume":"3","author":"Montgomerie","year":"1973","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/AAC.6.1.84","article-title":"Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against Gram-negative bacilli","volume":"6","author":"Rosenblatt","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.6.4.521","article-title":"Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia","volume":"6","author":"Nord","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/AAC.9.2.201","article-title":"Sulfamethoxazole\u2013trimethoprim\u2013polymyxin therapy of serious multiply drug-resistant Serratia infections","volume":"9","author":"Thomas","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.2042-7158.1993.tb05527.x","article-title":"Investigation of synergism between combinations of ciprofloxacin, polymyxin, sulphadiazine and p-aminobenzoic acid","volume":"45","author":"Richards","year":"1993","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0732-8893(02)00443-1","article-title":"Synergy of colistin with rifampicin and trimethoprim\/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia","volume":"44","author":"Giamarellos-Bourboulis","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.027_bib0150","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ijantimicag.2015.09.008","article-title":"In vitro activity of \u2018old antibiotics\u2019 against highly resistant Gram-negative bacteria","volume":"46","author":"Dubourg","year":"2015","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918300384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918300384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T04:53:42Z","timestamp":1570683222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918300384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0924857918300384"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.01.027","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}